Kyungki-do, South Korea

Jae Jin Han

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Dong Wha Pharm. Co., Ltd.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Jin Han. Retrieved from https://idiyas.com/inventor/jae-jin-han-g8oeg77g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jae Jin Han in Anti-Viral Agents

Introduction

Jae Jin Han is a notable inventor based in Kyungki-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-viral agents. His work focuses on innovative compounds that have the potential to combat serious viral infections.

Latest Patents

Jae Jin Han holds a patent for 2,5-pyridinedicarboxylic acid derivatives. These compounds have been identified as anti-viral agents, specifically targeting viruses such as hepatitis B and human immunodeficiency virus. The preparation method for these derivatives is also described in his patent, highlighting their potential utility in medical applications.

Career Highlights

Currently, Jae Jin Han is associated with Dong Wha Pharm. Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His dedication to developing effective treatments for viral infections showcases his commitment to improving public health.

Collaborations

Some of his notable coworkers include Sung Joon Yoon and Sang Wook Lee. Their collaborative efforts contribute to the ongoing research and development initiatives at Dong Wha Pharm. Co., Ltd.

Conclusion

Jae Jin Han's innovative work in the field of anti-viral agents represents a significant advancement in pharmaceutical research. His contributions have the potential to make a meaningful impact on the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…